Pediatrix Medical Group Management
Management Kriterienprüfungen 3/4
Pediatrix Medical Group CEO ist Jim Swift , ernannt in Jan 2023, hat eine Amtszeit von 1.83 Jahren. Die jährliche Gesamtvergütung beträgt $2.24M , bestehend aus 29% Gehalt und 71% Boni, einschließlich Aktien und Optionen des Unternehmens. besitzt direkt 0.2% der Aktien des Unternehmens, im Wert von $2.59M . Die durchschnittliche Betriebszugehörigkeit des Managementteams und des Verwaltungsrats beträgt 2.1 Jahre bzw. 4.3 Jahre.
Wichtige Informationen
Jim Swift
Geschäftsführender
US$2.2m
Gesamtvergütung
| Prozentsatz des Geschäftsführergehalts | 29.0% |
| Amtszeit als Geschäftsführer | 1.8yrs |
| Eigentum des Geschäftsführers | 0.2% |
| Durchschnittliche Amtszeit des Managements | 2.1yrs |
| Durchschnittliche Amtszeit der Vorstandsmitglieder | 4.3yrs |
Jüngste Management Updates
Recent updates
Here's Why Pediatrix Medical Group (NYSE:MD) Has A Meaningful Debt Burden
Oct 19
We Like These Underlying Return On Capital Trends At Pediatrix Medical Group (NYSE:MD)
Sep 28Improved Revenues Required Before Pediatrix Medical Group, Inc. (NYSE:MD) Stock's 32% Jump Looks Justified
Aug 07Does Pediatrix Medical Group (NYSE:MD) Have A Healthy Balance Sheet?
Jun 19Pediatrix Medical Group (NYSE:MD) Has Some Way To Go To Become A Multi-Bagger
May 10Pediatrix Medical Group, Inc.'s (NYSE:MD) Price Is Right But Growth Is Lacking
Mar 29Pediatrix Medical Group, Inc.'s (NYSE:MD) Intrinsic Value Is Potentially 100% Above Its Share Price
Jan 10Pediatrix Medical Group, Inc.'s (NYSE:MD) Earnings Are Not Doing Enough For Some Investors
Dec 25Is Pediatrix Medical Group (NYSE:MD) A Risky Investment?
Nov 14Is It Time To Consider Buying Pediatrix Medical Group, Inc. (NYSE:MD)?
Oct 13Does Pediatrix Medical Group (NYSE:MD) Have A Healthy Balance Sheet?
Aug 09Pediatrix: Unable To Deploy Capital Tied Up In Cash Conversion Cycle, Reiterate Hold
Aug 08At US$14.21, Is Pediatrix Medical Group, Inc. (NYSE:MD) Worth Looking At Closely?
Jul 03The Returns At Pediatrix Medical Group (NYSE:MD) Aren't Growing
Jun 08Pediatrix Medical Group (NYSE:MD) Has A Somewhat Strained Balance Sheet
Apr 26Is Now An Opportune Moment To Examine Pediatrix Medical Group, Inc. (NYSE:MD)?
Feb 20Pediatrix Medical Group Q4 2022 Earnings Preview
Feb 16Is Pediatrix Medical Group (NYSE:MD) A Risky Investment?
Jan 12Pediatrix: RCM Overhang Now Too Heavy, Revise To Hold
Dec 22Return Trends At Pediatrix Medical Group (NYSE:MD) Aren't Appealing
Dec 20Pediatrix appoints James Swift as chief executive officer
Dec 15Why Pediatrix Medical Group, Inc. (NYSE:MD) Could Be Worth Watching
Nov 05Pediatrix Medical Group GAAP EPS of $0.37 misses by $0.11, revenue of $489.92M misses by $21.54M
Nov 03Pediatrix: These 5 Graphs Suggest It's A Buy
Sep 29Here's Why Pediatrix Medical Group (NYSE:MD) Can Manage Its Debt Responsibly
Sep 13Here's What To Make Of Pediatrix Medical Group's (NYSE:MD) Decelerating Rates Of Return
Aug 29Why Pediatrix Medical Group, Inc. (NYSE:MD) Could Be Worth Watching
Jul 27Pediatrix: Seeking 46% Return Objective As Speculative Buy
Jul 14MEDNAX, Inc. (NYSE:MD) Shares Could Be 47% Below Their Intrinsic Value Estimate
Jun 24MEDNAX (NYSE:MD) Has A Pretty Healthy Balance Sheet
May 25Return Trends At MEDNAX (NYSE:MD) Aren't Appealing
Apr 20MEDNAX, Inc.'s (NYSE:MD) Intrinsic Value Is Potentially 96% Above Its Share Price
Mar 08MEDNAX (NYSE:MD) Seems To Use Debt Quite Sensibly
Feb 15Here's What's Concerning About MEDNAX's (NYSE:MD) Returns On Capital
Jan 19Analyse der Geschäftsführervergütung
| Datum | Gesamtvergütung | Gehalt | Unternehmensgewinne |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$254m |
| Jun 30 2024 | n/a | n/a | -US$252m |
| Mar 31 2024 | n/a | n/a | -US$71m |
| Dec 31 2023 | US$2m | US$650k | -US$60m |
| Sep 30 2023 | n/a | n/a | US$88m |
| Jun 30 2023 | n/a | n/a | US$95m |
| Mar 31 2023 | n/a | n/a | US$98m |
| Dec 31 2022 | US$1m | US$450k | US$63m |
Vergütung im Vergleich zum Markt: JimDie Gesamtvergütung ($USD2.24M) liegt unter dem Durchschnitt von Unternehmen ähnlicher Größe auf dem Markt US ($USD5.64M).
Entschädigung vs. Einkommen: JimDie Bezüge der Mitarbeiter sind gestiegen, während das Unternehmen unrentabel ist.
Geschäftsführer
Jim Swift (62 yo)
1.8yrs
Amtszeit
US$2,237,839
Vergütung
Dr. James D. Swift, M.D., also known as Jim, is Director of Brave Care, Inc. since October 2021. He had been the Chief Operating Officer at Pediatrix Medical Group, Inc. since May 2022 until December 31, 2...
Führungsteam
| Name | Position | Amtszeit | Vergütung | Eigentümerschaft |
|---|---|---|---|---|
| CEO & Director | 1.8yrs | US$2.24m | 0.20% $ 2.6m | |
| Executive VP | 2.1yrs | US$1.83m | 0.19% $ 2.4m | |
| Executive VP | less than a year | keine Daten | 0.052% $ 665.6k | |
| Senior VP & Chief Accounting Officer | 8.5yrs | US$1.43m | keine Daten | |
| Senior VP & Chief Information Officer | 2.8yrs | keine Daten | keine Daten | |
| Senior Vice President of Administration & Managed Care | no data | keine Daten | keine Daten | |
| Senior VP of Finance | no data | keine Daten | keine Daten | |
| Senior VP | 3.3yrs | keine Daten | keine Daten | |
| Senior Vice President of People Services | less than a year | keine Daten | keine Daten | |
| President of Regional Operations (Central) | no data | keine Daten | keine Daten | |
| President of Regional Operations (South-Central) | no data | keine Daten | keine Daten | |
| Senior Vice President of Operations | no data | keine Daten | keine Daten |
2.1yrs
Durchschnittliche Betriebszugehörigkeit
62yo
Durchschnittliches Alter
Erfahrenes Management: MDDas Führungsteam des Unternehmens gilt als erfahren (2.1 Jahre durchschnittliche Betriebszugehörigkeit).
Vorstandsmitglieder
| Name | Position | Amtszeit | Vergütung | Eigentümerschaft |
|---|---|---|---|---|
| CEO & Director | 1.7yrs | US$2.24m | 0.20% $ 2.6m | |
| Chair | 4.3yrs | US$554.45k | 0.20% $ 2.5m | |
| Lead Independent Director | 4.3yrs | US$295.00k | 0.081% $ 1.0m | |
| Independent Director | 4.3yrs | US$252.50k | 0.065% $ 831.1k | |
| Independent Director | 1.5yrs | US$201.00k | 0.035% $ 444.0k | |
| Independent Director | 4.3yrs | US$230.00k | 0.065% $ 831.0k | |
| Independent Director | 4.3yrs | US$245.00k | 0.043% $ 547.9k | |
| Board Observer | 4.3yrs | keine Daten | keine Daten | |
| Independent Director | 5.5yrs | US$242.50k | 0.069% $ 884.5k | |
| Independent Director | 2.5yrs | US$230.00k | 0.023% $ 295.8k |
4.3yrs
Durchschnittliche Betriebszugehörigkeit
61yo
Durchschnittliches Alter
Erfahrener Vorstand: MDDie Vorstandsmitglieder gelten als erfahren (4.3 Jahre durchschnittliche Amtszeit).